MASAŘÍK, Michal, Jaromír GUMULEC, Šárka KUCHTÍČKOVÁ, Vojtěch ADAM, Soňa KŘÍŽKOVÁ and René KIZEK. Detection of metallothionein and alpha-methylacyl CoA racemase as potential new markers for prostate carcinoma. International Journal of Molecular Medicine. 2009, vol. 24, Suppl. 1, 83 pp. ISSN 1107-3756.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Detection of metallothionein and alpha-methylacyl CoA racemase as potential new markers for prostate carcinoma
Name in Czech Detekce metalothioneinu a alpha-methylacyl CoA racemázy jako potenciálních markerů karcinomu prostaty
Authors MASAŘÍK, Michal, Jaromír GUMULEC, Šárka KUCHTÍČKOVÁ, Vojtěch ADAM, Soňa KŘÍŽKOVÁ and René KIZEK.
Edition International Journal of Molecular Medicine, 2009, 1107-3756.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Greece
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.980
Organization unit Faculty of Medicine
UT WoS 000270497500177
Keywords in English prostate carcinoma; tumor markers; metallothionein; AMACR
Tags International impact, Reviewed
Changed by Changed by: prof. RNDr. Michal Masařík, Ph.D., učo 21142. Changed: 19/1/2010 11:04.
Abstract
In many developed countries, prostate cancer is the second leading cause of cancer-related deaths among men. Therefore, having reliable and easy-to-detect marker is needed to treat this disease successfully. Metallothioneins (MT) are a group of proteins rich in cysteine with molecular weights ranging from 6 to 10 kDa. Their main physiological functions are homeostatic control and detoxification of the metals. The role of MT in tumour tissue remains still unclear, but MT can be considered as new promising tumour marker. Besides MT, alpha-methylacyl CoA racemase AMACR has been proven to be one of the few biomarkers that can help distinguish cancer from benign cells, with high sensitivity and specificity for prostate carcinoma. In this study we proposed new methodical approaches in MT and AMACR detection in cell line model and then reciprocal correlation of obtained data. The LNCaP cell line used in our experiments was isolated in 1977 by J.S. Horoszewicz, et al. An adsorptive transfer stripping technique coupled with differential pulsed voltammetry Brdicka reaction was employed for the determination of metallothionein MT and AMACR level in cell lines extract. MT content was hundred of ug per g of soluble proteins and was higher as well as for AMACR compared to non-tumour cell line.
Abstract (in Czech)
Práce popisuje detekci metalothioneinu a alpha-methylacyl CoA racemázu jako možných markerů pro diagnostiku karcinomu prostaty. Detekce byla prováděna standardními molekulárně-biologickými technikami a elektrochemickým přístupem.
Links
GP301/09/P436, research and development projectName: Analýza metalothioneinu u karcinomu prostaty na úrovni DNA, RNA a proteinu.
Investor: Czech Science Foundation
PrintDisplayed: 29/7/2024 21:09